Leukopenia and Thrombocytopenia As Adverse Effects of Treatment with 5-Aminosalicylic Suppositories

Journal of Clinical Gastroenterology

Volumn 22, Issue 2, 1996, Pages 160-161

  Casellas, F ^a   Vallano, A ^a   Malagelada, J R ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MESALAZINE;

ADULT; ARTICLE; CASE REPORT; COLONOSCOPY; DIARRHEA; DRUG EFFECT; FEMALE; FEVER; HUMAN; LEUKOPENIA; MALAISE; PRIORITY JOURNAL; RECTAL DRUG ADMINISTRATION; SUPPOSITORY; THROMBOCYTOPENIA; ULCERATIVE COLITIS;

ADULT; AMINOSALICYLIC ACIDS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLITIS, ULCERATIVE; FEMALE; HUMANS; LEUKOPENIA; MESALAMINE; SUPPOSITORIES; THROMBOCYTOPENIA;

EID: 0030052656     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-199603000-00023     Document Type: Article

References (8)

1. 99mTc-labeled 5-ASA suppositories. Dig Dis Sci 1987;32(suppl 12):71S-5S.
2. Fischer C, Maier K, Stumpf E, von Garsberg U, Klotz U. Disposition of 5-aminosalicylic acid, the active metabolite of sulphasalazine in man. Eur J Clin Pharmacol 1983;25:511-5.
3. Norlander B, Gotthard R, Ström M. Pharmacokinetics of a 5-aminosalicylic acid enteric-coated tablet and suppository dosage form. Aliment Pharmacol Ther 1989;3:333-42.
4. Wyatt S, Joyner MV, Daneshmend TK. Filgastrim for mesalazine-associated neutropenia. Lancet 1993;341:1476.
5. Bodin F, Biour M, Grange JD. Leucopénies au decours de la prise de sulfasalazine puis de mesalazine chez un même patient. Therapie 1991;48:339-41.
6. Turunen U, Elomaa I, Anthla VI, Seppala K. Mesalazine tolerance in patients with inflammatory bowel disease and previous intolerance or allergy to sulphasalazine or sulphonamides. Scand J Gastroenterol 1987;22:798-802.
7. Daneshmend TK. Mesalazine-associated thrombocytopenia. Lancet 1991;337:1297-8.
8. Laidlaw ST, Reilly JT. Antilymphocyte globulin for mesalazine-associated aplastic anemia. Lancet 1994;343:981-2.